Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Biomedical Engineering (2)
Nature Biotechnology (1)
Nature Cardiovascular Research (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cell biology
Molecular biology
Molecular medicine
Nanoscience and technology
Physiology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Allison N. Reiter Clear advanced filters

Vaccine Technology: Adjuvants for Increased Efficacy

Anthony C. Allison
Noelene E. Byars
Research01 Oct 1987
Bio/Technology

Volume: 5, P: 1041-1045
Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program

Elrod and colleagues reveal the role of ATP-citrate lyase in myofibroblast differentiation and cardiac fibrosis.

Michael P. Lazaropoulos
Andrew A. Gibb
John W. Elrod
ResearchOpen Access05 Jul 2024
Nature Cardiovascular Research

Volume: 3, P: 869-882
Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Matthew R. Golder
Jenny Liu
Jeremiah A. Johnson
Amendments and Corrections03 Sept 2018
Nature Biomedical Engineering

Volume: 2, P: 707
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Macromolecular telmisartan prodrugs optimized for preferential release in fibrotic liver tissue reduce liver fibrosis in mouse models, and are retained and well tolerated in the liver tissue of rats and dogs.

Matthew R. Golder
Jenny Liu
Jeremiah A. Johnson
Research20 Aug 2018
Nature Biomedical Engineering

Volume: 2, P: 822-830

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Italy
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Filter By:

Vaccine Technology: Adjuvants for Increased Efficacy

Nuclear ATP-citrate lyase regulates chromatin-dependent activation and maintenance of the myofibroblast gene program

Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

Search

Quick links